Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozone vs PRGF in Knee Osteoarthritis
NCT05837494Completed
- Sponsor
- Tanta University
- Start
- Jun 2022
- Primary completion
- May 2023
- Modality
- Inhalation Devices, Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial in knee osteoarthritis (OA) comparing Group ozone with Group PRGF (2 arms). Primary endpoints: knee osteoarthritis pain at 6 months and Decrease of Analgesic requirement for pain control at 6 months. Started Jun 2022; status: completed.
02
Drugs
medical ozonated waterPRGF-Endoret
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05837494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05837494.